Reproducibility of inhaled and subcutaneous insulin in Type 2 diabetic patients

被引：0
|
作者：
Perera, AD
Kapitza, C
Nosek, L
Heinemann, LW
Shapiro, DA
Fishman, RS
Heise, TC
机构：
[1] Aerogen Inc, Sunnyvale, CA USA
[2] Profil Inst Metab Res, Neuss, Germany
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
815
引用
收藏
页码：A212 / A212
页数：1
相关论文
共 50 条
  • [31] SALIVARY IMMUNOREACTIVE INSULIN IN TYPE-I DIABETIC-PATIENTS AFTER SUBCUTANEOUS INJECTION OF INSULIN
    MARCHETTI, P
    BENZI, L
    MASONI, A
    CECCHETTI, P
    GIANNARELLI, R
    DICIANNI, G
    GIOVANNITTI, MG
    CICCARONE, AM
    NAVALESI, R
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1986, 30 (04): : 185 - 189
  • [32] Impaired subcutaneous insulin delivery in type 2 diabetes patients
    Fryk, E.
    Olausson, J.
    Strindberg, L.
    Becattini, B.
    Mossberg, K.
    Schmelz, M.
    Brogren, H.
    Solinas, G.
    Jansson, P. -A.
    DIABETOLOGIA, 2018, 61 : S238 - S238
  • [33] COMBINED CONTINUOUS SUBCUTANEOUS INSULIN INFUSION AND MULTIPLE SUBCUTANEOUS INJECTIONS IN TYPE-I DIABETIC-PATIENTS
    SCHIFFRIN, A
    BELMONTE, M
    DIABETES CARE, 1981, 4 (06) : 595 - 600
  • [34] Continuous glucose monitoring in type 1 diabetic patients with continuous subcutaneous insulin infusion
    Alves, Marta
    Neves, Celestino
    Varela, Ana
    Arteiro, Cristina
    Pereira, Luis M.
    Carvaiho, Davide
    Medina, Jose L.
    DIABETES, 2008, 57 : A547 - A547
  • [35] REDUCTION OF COMPLICATIONS AND ASSOCIATED COSTS FOR TYPE 2 DIABETIC PATIENTS USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE UK
    Roze, S.
    Duteil, E.
    Hallas, N.
    de Portu, S.
    VALUE IN HEALTH, 2015, 18 (07) : A360 - A360
  • [36] Constant subcutaneous insulin infusion versus long-acting insulin injection as supplement to oral anti-diabetic drugs in type 2 diabetic patients
    Parkner, Tina
    Laursen, Torben
    Lauritzen, Torsten
    Smedegaard, Jorgen S.
    Christiansen, Jens S.
    DIABETES, 2007, 56 : A551 - A551
  • [37] Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with Type 2 diabetes mellitus.
    Mudaliar, S
    Henry, RR
    Fryburg, DA
    Becker, RHA
    Willavize, SA
    Fisher, JM
    Fountaine, R
    Sha, S
    DIABETOLOGIA, 2003, 46 : A277 - A278
  • [38] Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients
    Pouwels, MJJ
    Tack, CJ
    Hermus, AR
    Lutterman, JA
    DIABETIC MEDICINE, 2003, 20 (01) : 76 - 79
  • [39] Glycooxidation in type 2 diabetic patients treated with insulin
    Dworacka, M.
    Szczawinska, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 50 - 50
  • [40] Insulin Requirement Profiles of Short-Term Continuous Subcutaneous Insulin Infusion Therapy in Chinese Patients with Type 2 Diabetic Nephropathy
    Lin, Shuo
    Zhang, Kuixing
    Li, Ping
    Fang, Ke
    Zeng, Longyi
    DIABETES, 2019, 68
12345